These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2128509)

  • 41. Inhibition of polyamine oxidase in rats improves the sensitivity of urinary polyamines as markers for cell death.
    Hessels J; Ferwerda H; Kingma AW; Muskiet FA
    Biochem J; 1990 Mar; 266(3):843-51. PubMed ID: 2327969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of some kinetic and molecular properties of microsomal and mitochondrial monoamine oxidase.
    Gómez N; Balsa D; Unzeta M
    Biochem Pharmacol; 1988 Sep; 37(18):3407-13. PubMed ID: 3421992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM; Chen RC; Chiueh CC
    Ann N Y Acad Sci; 2000; 899():255-61. PubMed ID: 10863544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K; Szende B
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification and characterization of polyamine oxidase from Ascaris suum.
    Müller S; Walter RD
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):75-80. PubMed ID: 1567380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amine oxidase released into plasma of rats treated with hepatotoxin allyl formate.
    Obata T; Egashira T; Yamanaka Y
    Res Commun Chem Pathol Pharmacol; 1989 Oct; 66(1):69-85. PubMed ID: 2515565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?
    Strolin Benedetti M; Tipton KF; Whomsley R
    Fundam Clin Pharmacol; 2007 Oct; 21(5):467-80. PubMed ID: 17868200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoamine oxidase inhibition by L-deprenyl depends on both sex and route of administration in the rat.
    Murphy MP; Wu PH; Milgram NW; Ivy GO
    Neurochem Res; 1993 Dec; 18(12):1299-304. PubMed ID: 8272194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of copper-dependent amine oxidases by some hydrazides of pyrrol-1-ylbenzoic and pyrrol-1-ylphenylacetic acids.
    Artico M; Corelli F; Massa S; Stefancich G; Avigliano L; Befani O; Marcozzi G; Sabatini S; Mondovi B
    J Med Chem; 1988 Apr; 31(4):802-6. PubMed ID: 3127589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the metabolism of dimethylnitrosamine in vitro by rat-liver preparations. II. Inhibition by substrates and inhibitors of monoamine oxidase.
    Lake BG; Harris RA; Collins MA; Cottrell RC; Phillips JC; Gangolli SD
    Xenobiotica; 1982 Sep; 12(9):567-79. PubMed ID: 6818776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoamine oxidase activities in lymphocytes and granulocytes taken from pig blood.
    Balsa D; Gómez N; Unzeta M
    Biochem Pharmacol; 1987 Sep; 36(17):2723-8. PubMed ID: 3632702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
    Fowler CJ; Oreland L; Callingham BA
    J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003
    [No Abstract]   [Full Text] [Related]  

  • 58. The rational design of suicide substrates of amine oxidases.
    Palfreyman MG; McDonald IA; Bey P; Danzin C; Zreika M; Lyles GA; Fozard JR
    Biochem Soc Trans; 1986 Apr; 14(2):410-3. PubMed ID: 3086155
    [No Abstract]   [Full Text] [Related]  

  • 59. Monoamine oxidases and related amine oxidases as phase I enzymes in the metabolism of xenobiotics.
    Strolin Benedetti M; Tipton KF
    J Neural Transm Suppl; 1998; 52():149-71. PubMed ID: 9564617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake.
    Fang J; Yu PH
    Neuropharmacology; 1994 Jun; 33(6):763-8. PubMed ID: 7936114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.